비침습적 혈당 모니터링 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 컴포넌트, 용도, 디바이스, 최종사용자, 기능, 솔루션

The global Non Invasive Glucose Monitoring Market is projected to grow from $407.5 Million in 2025 to $643.2 Million by 2035, at a compound annual growth rate (CAGR) of 4.6%. The global non-invasive glucose monitoring market remains an emerging technology segment, and major government agencies do not publish a standardized global market-size or CAGR estimate specifically for this category. Demand is supported by the expanding diabetes population and increasing acceptance of digital glucose monitoring. The CDC estimates that 40.1 million people in the United States had diagnosed or undiagnosed diabetes in 2023, while 115.2 million adults had prediabetes. FDA activity also indicates continued development of connected glucose technologies, including the Biolinq Shine autonomous time-in-range microsensor and OTC glucose-monitoring systems. These developments reinforce demand for less burdensome monitoring approaches.

Optical glucose monitoring uses techniques such as near-infrared, mid-infrared, Raman spectroscopy, and photonic sensing to estimate glucose concentrations through tissue or skin, while electromagnetic systems analyze glucose-related changes using radiofrequency, microwave, or electromagnetic interactions. Optical approaches benefit from advances in miniaturized photonics, spectroscopy, signal processing, and artificial intelligence, whereas electromagnetic platforms emphasize sensor integration and contactless measurement. Both technologies aim to eliminate finger-pricking and reduce dependence on invasive sensors. Optical systems currently attract substantial research and commercialization interest because of their compatibility with wearable formats. Growth prospects remain strong as developers improve accuracy, calibration stability, interference compensation, and clinical validation.

Real-time monitoring continuously estimates glucose levels and delivers dynamic readings, alerts, trend information, and digital insights through connected devices, supporting proactive diabetes and metabolic management. Intermittent monitoring captures glucose measurements at defined intervals or on user initiation, offering lower monitoring intensity and potentially simpler device architectures. Real-time functionality is gaining importance because users increasingly seek continuous visibility into glucose responses associated with meals, exercise, medication, and daily routines. FDA-authorized digital glucose-monitoring technologies demonstrate expanding regulatory activity in connected monitoring. The non-invasive segment is expected to develop further as sensor miniaturization and algorithms enable more frequent measurements without skin penetration.

Geographical Overview

North America maintains a strong position in non-invasive glucose monitoring development because of its advanced medical-device infrastructure, large diabetes-management ecosystem, substantial R&D capabilities, and established reimbursement pathways for glucose-monitoring technologies. The United States provides an important regulatory and commercialization environment, with the FDA maintaining extensive authorization activity for connected glucose-monitoring systems. The region also benefits from significant demand for convenient home-based and wearable monitoring. The CDC reports that continuous glucose monitors are increasingly available to people with diabetes, prediabetes, and some consumers seeking metabolic insights. Strong biotechnology investment, digital-health integration, clinical research, and regulatory development are expected to support continued commercialization.

Europe presents substantial opportunities as healthcare systems emphasize preventive care, digital health, patient-centered monitoring, and improved diabetes management. Adoption of wearable glucose technologies is supported by established healthcare infrastructure, increasing digital-health investment, and demand for less burdensome monitoring methods. European technology developers are also advancing sensor miniaturization, spectroscopy, biosensing, and AI-based interpretation, creating an ecosystem for next-generation non-invasive platforms. Expansion of connected-care models and remote patient monitoring can improve integration between glucose-monitoring devices, smartphones, healthcare professionals, and digital therapeutics. Regulatory compliance and clinical validation remain important considerations, but increasing healthcare digitization and demand for continuous metabolic information should support long-term market development.

Key Trends and Drivers

The Rise of Contactless Glucose Intelligence:

The market is moving toward wearable, AI-enabled, and contactless glucose sensing that integrates monitoring with broader digital-health ecosystems. Developers are combining advanced optical and electromagnetic sensing with machine learning, miniaturized electronics, smartphone connectivity, and cloud analytics to improve measurement frequency and user convenience. FDA databases show continued authorization activity for wearable and connected glucose-monitoring technologies, indicating sustained technological development. The longer-term direction is toward smaller, less intrusive devices capable of generating continuous metabolic insights while reducing dependence on conventional finger-prick or implanted sensing approaches.

The Growing Demand for Needle Free Diabetes Management:

The increasing burden of diabetes and demand for convenient glucose management are major factors supporting investment in non-invasive monitoring technologies. The CDC estimates 40.1 million Americans had diagnosed or undiagnosed diabetes and 115.2 million adults had prediabetes, creating a substantial addressable population for easier glucose assessment. Consumers and healthcare providers increasingly value frequent glucose information for understanding treatment response, dietary patterns, physical activity, and metabolic changes. Existing CGM adoption also demonstrates demand for automated monitoring, while advances in sensors, wireless connectivity, AI algorithms, and wearable electronics are improving the feasibility of transitioning toward completely non-invasive platforms.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Component
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Device
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Optical Glucose Monitoring
  • 4.1.2 Transdermal Glucose Monitoring
  • 4.1.3 Enzymatic Glucose Monitoring
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Wearable Devices
  • 4.2.2 Non-Wearable Devices
  • 4.2.3 Continuous Glucose Monitors
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Near-Infrared Spectroscopy
  • 4.3.2 Mid-Infrared Spectroscopy
  • 4.3.3 Raman Spectroscopy
  • 4.3.4 Photoacoustic Spectroscopy
  • 4.3.5 Fluorescence Technology
  • 4.3.6 Others
• 4.4 Market Size & Forecast by Component (2020-2035)
  • 4.4.1 Sensors
  • 4.4.2 Transmitters
  • 4.4.3 Receivers
  • 4.4.4 Software
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Diabetes Management
  • 4.5.2 Blood Glucose Testing
  • 4.5.3 Others
• 4.6 Market Size & Forecast by Device (2020-2035)
  • 4.6.1 Smart Watches
  • 4.6.2 Smart Patches
  • 4.6.3 Handheld Devices
  • 4.6.4 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals
  • 4.7.2 Home Care Settings
  • 4.7.3 Diagnostic Centers
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Real-Time Monitoring
  • 4.8.2 Intermittent Monitoring
  • 4.8.3 Others
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Data Management Solutions
  • 4.9.2 Remote Monitoring Solutions
  • 4.9.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Component
    • 5.2.1.5 Application
    • 5.2.1.6 Device
    • 5.2.1.7 End User
    • 5.2.1.8 Functionality
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Component
    • 5.2.2.5 Application
    • 5.2.2.6 Device
    • 5.2.2.7 End User
    • 5.2.2.8 Functionality
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Component
    • 5.2.3.5 Application
    • 5.2.3.6 Device
    • 5.2.3.7 End User
    • 5.2.3.8 Functionality
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Component
    • 5.3.1.5 Application
    • 5.3.1.6 Device
    • 5.3.1.7 End User
    • 5.3.1.8 Functionality
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Component
    • 5.3.2.5 Application
    • 5.3.2.6 Device
    • 5.3.2.7 End User
    • 5.3.2.8 Functionality
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Component
    • 5.3.3.5 Application
    • 5.3.3.6 Device
    • 5.3.3.7 End User
    • 5.3.3.8 Functionality
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Component
    • 5.4.1.5 Application
    • 5.4.1.6 Device
    • 5.4.1.7 End User
    • 5.4.1.8 Functionality
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Component
    • 5.4.2.5 Application
    • 5.4.2.6 Device
    • 5.4.2.7 End User
    • 5.4.2.8 Functionality
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Component
    • 5.4.3.5 Application
    • 5.4.3.6 Device
    • 5.4.3.7 End User
    • 5.4.3.8 Functionality
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Component
    • 5.4.4.5 Application
    • 5.4.4.6 Device
    • 5.4.4.7 End User
    • 5.4.4.8 Functionality
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Component
    • 5.4.5.5 Application
    • 5.4.5.6 Device
    • 5.4.5.7 End User
    • 5.4.5.8 Functionality
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Component
    • 5.4.6.5 Application
    • 5.4.6.6 Device
    • 5.4.6.7 End User
    • 5.4.6.8 Functionality
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Component
    • 5.4.7.5 Application
    • 5.4.7.6 Device
    • 5.4.7.7 End User
    • 5.4.7.8 Functionality
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Component
    • 5.5.1.5 Application
    • 5.5.1.6 Device
    • 5.5.1.7 End User
    • 5.5.1.8 Functionality
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Component
    • 5.5.2.5 Application
    • 5.5.2.6 Device
    • 5.5.2.7 End User
    • 5.5.2.8 Functionality
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Component
    • 5.5.3.5 Application
    • 5.5.3.6 Device
    • 5.5.3.7 End User
    • 5.5.3.8 Functionality
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Component
    • 5.5.4.5 Application
    • 5.5.4.6 Device
    • 5.5.4.7 End User
    • 5.5.4.8 Functionality
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Component
    • 5.5.5.5 Application
    • 5.5.5.6 Device
    • 5.5.5.7 End User
    • 5.5.5.8 Functionality
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Component
    • 5.5.6.5 Application
    • 5.5.6.6 Device
    • 5.5.6.7 End User
    • 5.5.6.8 Functionality
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Component
    • 5.6.1.5 Application
    • 5.6.1.6 Device
    • 5.6.1.7 End User
    • 5.6.1.8 Functionality
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Component
    • 5.6.2.5 Application
    • 5.6.2.6 Device
    • 5.6.2.7 End User
    • 5.6.2.8 Functionality
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Component
    • 5.6.3.5 Application
    • 5.6.3.6 Device
    • 5.6.3.7 End User
    • 5.6.3.8 Functionality
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Component
    • 5.6.4.5 Application
    • 5.6.4.6 Device
    • 5.6.4.7 End User
    • 5.6.4.8 Functionality
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Component
    • 5.6.5.5 Application
    • 5.6.5.6 Device
    • 5.6.5.7 End User
    • 5.6.5.8 Functionality
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Abbott Laboratories
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Dexcom
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Medtronic
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Roche
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Senseonics
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 GlucoTrack
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Nemaura Medical
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Integrity Applications
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 C8 MediSensors
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 DiaMonTech
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Echo Therapeutics
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 GlySens
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 NovioSense
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Biolinq
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Afon Technology
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 PKvitality
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 POCTech
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 HemoCue
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 LifeScan
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Ascensia Diabetes Care
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us